Related Experiment Videos
Leukocyte protein tyrosine kinases: potential targets for drug discovery
1DNAX Research Institute, Palo Alto, California 94304, USA. joseph_bolen@dnax.org
Abstract:
Intracellular signal transduction following the extracellular ligation of a wide variety of different types of surface molecules on leukocytes involves the activation of protein tyrosine kinases. The dependence of successful intracellular signaling on the functions of the nontransmembrane class of protein tyrosine kinases coupled with the cell type-specific expression patterns for several of these enzymes makes them appealing targets for therapeutic intervention. Development of drugs that can interfere with the catalytic functions of the nontransmembrane protein tyrosine kinases or that can disrupt critical interactions with regulatory molecules and/or substrates should find clinical applications in the treatment of allergic diseases, autoimmunity, transplantation rejection, and cancer.
Insights
Protein tyrosine kinases are crucial for leukocyte signaling. Targeting these enzymes offers potential treatments for immune disorders and cancer.
Area of Science:
- Biochemistry
- Immunology
- Pharmacology
Background:
- Leukocyte surface molecule ligation triggers intracellular signal transduction.
- Protein tyrosine kinases (PTKs) are essential for this signaling pathway.
- Nontransmembrane PTKs play a critical role in intracellular signaling.
Purpose of the Study:
- To highlight the therapeutic potential of targeting nontransmembrane protein tyrosine kinases.
- To explore the role of PTKs in various immune and disease states.
Main Methods:
- Review of intracellular signal transduction mechanisms in leukocytes.
- Analysis of the role of nontransmembrane protein tyrosine kinases.
- Examination of cell type-specific expression patterns of PTKs.
Main Results:
- Nontransmembrane PTKs are indispensable for successful intracellular signaling.
- Specific PTKs exhibit cell type-specific expression, indicating targeted therapeutic possibilities.
- Dysregulation of PTK activity is implicated in various diseases.
Conclusions:
- Nontransmembrane protein tyrosine kinases are attractive therapeutic targets.
- Drug development aimed at inhibiting PTK catalytic activity or disrupting interactions is promising.
- Interventions targeting PTKs could treat allergic diseases, autoimmunity, transplant rejection, and cancer.